Table 2.

Percentage of residual AS13 antimicrobial activity after treatment with enzymes

Treatment	E. faecalis	S. aureus	E. coli	S. Enteritidis
No one	100 (89.51)	100 (95.2)	100 (90.42)	100 (92.63)
α-Chymotrypsin (2.5 mg mL−1)	26.50*	41.56	29.20*	62.12
Lipase (2.5 mg mL−1)	60.95	95.38	56.31	77.02
Trypsin (2.5 mg mL−1)	68.50	63.91	56.34	88.62
Proteinase K (1 mg mL−1)	31.66*	41.37	40.52	60.33
Amylase (2.5 mg mL−1)	58.06	54.58	43.31	66.88

Antimicrobial activity of supernatant AS13 without the addition of enzymes is 100%

In brackets: absolute inhibitory activity (I.A.)

^*Significant difference p < 0.05